" Perhaps one of the most misunderstood aspects of a cord blood bank is financial stability, as your child's cord blood will be banked for up to, or in some cases, greater than 18 years.

We have noted that some cord blood banks are eager to point out that they are publicly traded on a stock exchange and perform research, claiming that this makes them more trustworthy; however, such activities do not directly benefit their clients: You do not want the stability of your child's cord blood to depend upon the volatilities of the stock market. Furthermore, publicly traded companies are typically under pressure from their many investors to "promise" a dramatic return on their investment. For this reason, it becomes necessary to consider risky research as a means of providing the appeal for a huge potential return. There is a possibility that the funds that should have gone into storing your child's cord blood are squandered on unnecessary marketing and research, in which the outcome is mostly unsuccessful; even if they are successful, are only of benefit to the shareholders, and not the clients "
                                                         - Cord Blood Association of Canada